Key Factors to Consider when Switching to Biosimilars

EP: 1.Comparing Biologics and Biosimilars

EP: 2.Biosimilar Utilization and Inventory Management

EP: 3.Operationalizing Biosimilars in Specialty Pharmacies

EP: 4.Advice for States that Require Prior Prescriber Approval for Substitution

Now Viewing

EP: 5.Key Factors to Consider when Switching to Biosimilars

EP: 6.Pharmacy and Provider Collaboration

EP: 7.Biosimilar Copay Programs

Video content above is prompted by the following:

• To what extent should the pharmacy team prioritize supporting the switch from a reference product to a biosimilar, and what factors should be considered in making this decision?